Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study

NCT: NCT07228286 · RECRUITING

NCT IDNCT07228286
StatusRECRUITING
Start Date2025-11-01
Completion2029-02-10
SponsorSamuel Snider, MD (OTHER)
First posted
Last updated

Brief Summary

The RE-CONNECT study is an early feasibility study to establish the safety, feasibility, and efficacy of two central thalamic deep brain stimulation targets in patients with chronic disorders of consciousness.

Frequently Asked Questions

What is REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study?

REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study is a clinical trial registered under NCT07228286. Current status: RECRUITING.

What is the status of NCT07228286?

The current status of NCT07228286 (REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study) is: RECRUITING.

When did REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study start?

REstoring CONsciousness With NEurostimulation of the Central Thalamus: The RECONNECT Study started on 2025-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑